Analysis | The Health 202: Who doesn't like the new North American trade deal? Pharma.
with Paulina Firozi THE PROGNOSIS Congress has yet to pass major legislation lowering U.S. drug prices. But there are signs within President Trump’s newly passed North American trade deal that the pharmaceutical industry’s grip on lawmakers may be slipping. The Senate gave the president his long-sought …
Read more on washingtonpost.com
The Washington Post flipped this story into Politics•1349d